We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Highly Sensitive Laser Scanning to Advance Antibody Discovery

By LabMedica International staff writers
Posted on 31 Aug 2010
A new framework for highly sensitive laser scanning is now available to cell biologists and other life scientists working in the field of antibody discovery.

The new "Mirrorball” system is manufactured by TTP LabTech (Royston, United Kingdom), who maintain that it addresses one of the currently unmet needs of laser scanning instrumentation – that of high sensitivity. More...
In addition, Mirrorball is advertised as the first laser scanning microplate cytometer to offer simultaneous laser scanning.

Mirrorball operates at high sensitivity that enables detection of proteins that are only found at low abundance. This ensures that the instrument is perfectly suited to mix-and-read assays for hybridoma screening and cell-surface receptor expression. Simultaneous laser scanning results in superior multiplexing and analytical capabilities that enable robust and rapid data generation. Label-free detection takes place concurrently with fluorescence measurements resulting in improved object recognition and fewer false negatives, based on individual object count. Minimal autofluorescence due to proprietary low loss optics and red 640 nm laser excitation leads to a high signal-to-noise ratio and guarantees robust data generation.

Dr. Wayne Bowen, CSO at TTP LabTech, said, "Mirrorball is TTP LabTech's response to requests from scientists for novel technologies in antibody discovery. We have listened, developed, and now delivered a high sensitivity microplate cytometer for fluorescence cellular screening.”

Related Links:

TTP LabTech




Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Hematology Consumables
Bioblood Devices
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The updated CRC screening guidance adds a stool RNA test and an updated stool DNA test to the menu of preferred options (image credit: Adobe Stock)

Updated Guidance Prioritizes Stool-Based Colorectal Cancer Screening Tests

Colorectal cancer is the second-leading cause of cancer death in the United States and claimed an estimated 55,000 lives in 2026. Incidence is rising among adults younger than 50, even as overall mortality... Read more

Immunology

view channel
Image: Study design for analysis of monocyte phenotype, function, and metabolism (Gráinne Jameson et al., Journal of Infection (2026). DOI: 10.1016/j.jinf.2026.106755)

Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response

Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.